《生命科学》 2015, 27(3): 237-248

我国肝癌研究的现状与前景

吕桂帅1，陈　磊1，王红阳1，2*

(1 第二军医大学东方肝胆外科医院，上海 200438；2 国家肝癌科学中心，上海 201805)

摘　要：摘 要：肝癌是病死率最高的恶性肿瘤之一。我国每年约有38.3 万人死于肝癌，占全球肝癌死亡病例数的51%，严峻的形势给我国的社会和医疗带来了沉重的负担。不断增加的科研经费投入为我国肝癌研究带来了快速发展的新机遇。主要介绍近年来我国科学家在肝癌流行病学、发病机制及诊疗方面取得的主要进展。

Research progress and prospect of liver cancer in China

LV Gui-Shuai1， CHEN Lei1， WANG Hong-Yang1，2*

(1 Eastern Hepatobiliary Surgery Hospital， Second Military Medical University， Shanghai 200438， China; 2 National Center for Liver Cancer， Shanghai 201805， China)

Abstract: Abstract: Primary liver cancer is the leading cause of cancer-related mortality in China， with approximately 383 000 deaths annually， accounting for 51% of the mortality of liver cancer worldwide. It is a global burden for Chinese society and public health to face with this heavy situation. Chinese scientists are industriously unveiling the mechanisms of liver cancer with ever-accelerated science and technology. Here we summarize recent findings in the field of liver cancer research and outlook involving mechanism， diagnosis and therapy in China.